Publications

Detailed Information

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer : 전이성 대장암에서 cetuximab 치료효과의 예측인자로서 KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status의 분석

DC Field Value Language
dc.contributor.advisor김태유-
dc.contributor.author박진현-
dc.date.accessioned2019-07-09T17:41:23Z-
dc.date.available2019-07-09T17:41:23Z-
dc.date.issued2011-08-
dc.identifier.other000000031993-
dc.identifier.urihttps://hdl.handle.net/10371/158300-
dc.identifier.urihttp://dcollection.snu.ac.kr:80/jsp/common/DcLoOrgPer.jsp?sItemId=000000031993ko_KR
dc.description학위논문 (석사)-- 서울대학교 대학원 : 의학과, 2011.8. 김태유.-
dc.format.extentv, 48장-
dc.language.isoeng-
dc.publisher서울대학교 대학원-
dc.subject대장암-
dc.subjectcetuximab-
dc.subject예측인자-
dc.subjectKRAS-
dc.subjectBRAF-
dc.subjectPTEN-
dc.subjectEGFR intron 1 CA-
dc.subjectcolon cancer-
dc.subjectpredictive factor-
dc.titleAnalysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer-
dc.title.alternative전이성 대장암에서 cetuximab 치료효과의 예측인자로서 KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status의 분석-
dc.typeThesis-
dc.typeDissertation-
dc.description.degreeMaster-
dc.contributor.affiliation의학과-
dc.date.awarded2011-08-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share